Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Active Pharmaceutical ingredient watch. (Markets).(Brief Article)
- ABBOTT Laboratories and NaPro Bio Therapeutics Inc. have received FDA approval to market paclitaxel injection, the generic equivalent of Bristol-Myers Squibb Company's anticancer compound Taxol. AKZO Nobel's Organon Inc. has filed suit in a federal district court against Barr Laboratories Inc. for...
- Research articles 2002-05-13
- Organon Gets First European Marketing Approval For Remeron
- CIMA LABS INC. (Nasdaq:CIMA), Eden Prairie, Minn., has announced that its pharmaceutical partner, Organon, has received its first European marketing approval for RemeronR SolTabTM from the Dutch Medicines Evaluation Board. The Dutch regulatory approval triggers a mutual recognition procedure involving other European countries. Remeron SolTab, an antidepressant that...
- Research articles 2001-09-01
Additional Resources
- FTC approves Cephalon plans to purchase Cima Labs Inc.
- Cephalon Inc., whose worldwide manufacturing operations are in Salt Lake City, was cleared by U.S. antitrust enforcers to complete its $515 million purchase of Cima Labs Inc. after agreeing to license fast-acting cancer-pain drug Actiq to a competitor. Cephalon, which is acquiring Cima's patented OraVescent technique for delivering...
- Research articles 2004-08-10
- Cima labs rejects bid from Cephalon.(breaking news Roundup)(Brief Article)
- Cima Labs Inc. has rejected Cephalon Inc.'s $384 million cash takeover bid, saying it is less favorable to stockholders than an earlier bid from aaiPhamaa Inc. The proposed merger with aaiPharma announced last month would ... Cima Labs Inc. has rejected Cephalon Inc.'s $384...
- Research articles 2003-09-08
- CIMA LABS Announces That Akzo Nobel And Organon Inc. Have Filed Patent Infringement Suit Against Barr Laboratories
- Business Editors EDEN PRAIRIE, Minn.--BUSINESS WIRE--May 3, 2002 CIMA LABS INC. (Nasdaq:CIMA) today announced that Akzo Nobel NV (Nasdaq:AKZOY) and its Organon Inc. pharmaceutical unit filed suit in the Federal District Court of Newark, N.J., today against Barr Laboratories, Inc. (NYSE:BRL), claiming that Barr has infringed on the...
- Research articles 2002-05-03
- CIMA LABS Announces Temporary Stock Repurchase Program
- Business Editors & Health/Medical Writers EDEN PRAIRIE, Minn.--BUSINESS WIRE--Sept. 17, 2001 CIMA LABS INC. (Nasdaq:CIMA) today announced that its Board of Directors has authorized a temporary stock repurchase program of up to $20.0 million in accordance with the emergency rules issued by the Securities and Exchange Commission SEC...
- Research articles 2001-09-17
- Pennsylvania-Based Drug Firm Cephalon to Buy Cima Labs.
- By Jim McCartney, Saint Paul Pioneer Press, Minn. Knight Ridder/Tribune Business News Nov. 4--The courting of Cima Labs Inc. appears to be over as the Eden Prairie-based drug company has signed a merger agreement that looks like it will stick. ...
- Research articles 2003-11-04
- CyDex Inc. (Jobs and People).(Names John M. Siebert president and CEO )
- John M. Siebert has been named president and CEO and appointed to the board of directors of CyDex Inc. Mr. Siebert has served in increasingly responsible positions in the pharmaceutical and over-the-counter product industries since 1967. He most recently served as president and CEO of CIMA...
- Research articles 2003-06-02
- StreetInsider.com's Stock Movers of Note - Part 2.
- M2 PRESSWIRE-21 August 2003-StreetInsider.com Inc.: StreetInsider.com's Stock Movers of Note - Part 2C1994-2003 M2 COMMUNICATIONS LTD RDATE:08212003 WINNERS: Aastrom Biosciences, Inc. (Nasdaq: ASTM), CIMA LABS INC. (Nasdaq: CIMA), Cephalon, Inc. (Nasdaq: CEPH), aaiPharma Inc. (Nasdaq: AAII), Dell Inc. ...
- Research articles 2003-08-21
- << Previous
- page 1 of 1
- Next >>
